KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Gains from Sales and Divestitures (2016 - 2017)

Tenet Healthcare (THC) has disclosed Gains from Sales and Divestitures for 9 consecutive years, with $960836.0 as the latest value for Q1 2017.

  • For Q1 2017, Gains from Sales and Divestitures fell 21.44% year-over-year to $960836.0; the TTM value through Mar 2017 reached $960836.0, down 21.44%, while the annual FY2016 figure was $1.6 million, 35.9% up from the prior year.
  • Gains from Sales and Divestitures hit $960836.0 in Q1 2017 for Tenet Healthcare, down from $1.6 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.6 million in Q4 2016 and bottomed at $839353.0 in Q1 2014.
  • Average Gains from Sales and Divestitures over 5 years is $1.1 million, with a median of $996363.0 recorded in 2015.
  • Year-over-year, Gains from Sales and Divestitures plummeted 76.04% in 2013 and then surged 41.41% in 2016.
  • Tenet Healthcare's Gains from Sales and Divestitures stood at $966838.0 in 2013, then increased by 4.46% to $1.0 million in 2014, then increased by 19.83% to $1.2 million in 2015, then soared by 35.9% to $1.6 million in 2016, then tumbled by 41.58% to $960836.0 in 2017.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $960836.0, $1.6 million, and $1.5 million for Q1 2017, Q4 2016, and Q3 2016 respectively.